Treatment & Management
The research led by this Think Tank aims to optimize treatment strategies for people living and aging with HIV and STBBIs to promote long-term engagement in care, reduce comorbidities, and improve quality of life.
-
CTN 326: LIVEHIV Cohort Plus
The role of fatty liver in the epidemic of advanced chronic liver disease among people living with HIV
-
CTN 331: DDI Study: Drug-drug interactions between ART and feminizing hormones in trans women living with HIV
Drug-drug interaction study between bictegravir/emtricitabine/tenofovir alafenamide and feminizing hormones in trans women living with HIV
-
CTN 330: Predicting and evaluating anal cancer in HIV with novel biomarkers (The PEACH Study)
Development and validation of an anal cancer screening algorithm in HIV-positive men who have sex with men
-
CTN 327: Impact of COVID-19 on persons with HIV in Canada
The impact of COVID-19 on persons with HIV in Canada: Data from the HIV/HCV co-infection/CCC (CTN 222) and HIV aging cohorts (CTN 314)
-
CTNPT 039: The I-Score/Opal Implementation Pilot Study
Electronic capture through the Opal patient portal of a patient-reported measure of barriers to antiretroviral therapy adherence: a mixed method type 3 hybrid pilot study at a large Montreal HIV clinic
-
CTNPT 035: Vitamin D insufficiency and NAFLD in persons living with HIV
Association of vitamin D insufficiency with non-alcoholic fatty liver disease in HIV mono-infected patients
-
CTN 272: Canadian HIV and Aging cohort
Determinants of Increased Risk of Cardiovascular Diseases in Individuals Living with HIV
-
CTNPT 011: Monitoring penicillin levels for syphilis
Penicillin therapeutic drug monitoring in the treatment of infectious syphilis. Do low serum penicillin concentrations correlate with treatment failure?
-
CTNPT 014: Kaletra®/Celsentri® combination therapy for HIV in the setting of HCV
An observational study of Kaletra®/Celsentri® combination therapy
-
CTNPT 015: COMO cognition study with HIV+ patients
Pilot project to implement a step-wise investigation that includes Cerebrospinal Fluid analysis as a standard of care for HIV+ individuals with cognitive symptoms
-
CTNPT 021: The (BATARI) Pilot Trial
Bone Antiresorptive Therapy with AntiRetroviral Initiation (BATARI) Pilot Trial